ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,344.16
0.47%
Dow Jones
39,497.54
0.13%
US Dollar vs MXN
18.8323
-0.18%
Brent Oil
79.485
0.95%
Bitcoin
60,220.15
-2.46%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
09/08/202416:40PR Newswire (Canada)REALnorth Opportunities Fund Provides Update on Wind-up of the Fund
09/08/202416:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNKBLINKBANCORP Inc
09/08/202416:37GlobeNewswire Inc.Ascot Reports Second Quarter 2024 ResultsTSX:AOTAscot Resources Ltd
09/08/202416:37Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LICYLi Cycle Holdings Corp
09/08/202416:36PR Newswire (Canada)Cocktail International Announces Inaugural Middle Eastern Expo in Oakville
09/08/202416:35PR Newswire (US)Maritime Security Market size is set to grow by USD 3.62 billion from 2024-2028, Growing marine threats boost the market, Technavio
09/08/202416:35PR Newswire (US)Peripheral Neuropathy Treatment Market size is set to grow by USD 447.3 million from 2024-2028, Increasing prevalence of peripheral neuropathy boost the market, Technavio
09/08/202416:34Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ASYSAmtech Systems Inc
09/08/202416:34PR Newswire (US)Ismael Cala supports female empowerment in Days to Shine
09/08/202416:31Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:MULNMullen Automotive Inc
09/08/202416:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INSMInsmed Inc
09/08/202416:30NEWSBTCOKX Takes Action: Accounts Involving Tornado Cash To Be BannedCOIN:BTCUSDBitcoin
09/08/202416:30Business WireCareMax Reports Second Quarter 2024 ResultsNASDAQ:CMAXCareMax Inc
09/08/202416:30GlobeNewswire Inc.CN Asks Federal Government to Order Binding Arbitration to Protect Canada’s EconomyNYSE:CNICanadian National Railway Co
09/08/202416:30PR Newswire (US)Capillary Electrophoresis Market size is set to grow by USD 308 million from 2024-2028, Increasing R and D expenditure boost the market, Technavio
09/08/202416:30PR Newswire (US)Marine Coatings Market size is set to grow by USD 4.85 billion from 2024-2028, Growth of shipbuilding industry to boost the market growth, Technavio
09/08/202416:30PR Newswire (Canada)CHESSWOOD ANNOUNCES SALE OF VAULT AND PROVIDES STRATEGIC REVIEW UPDATETSX:CHWChesswood Group Limited
09/08/202416:29Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SKYESkye Bioscience Inc
09/08/202416:29Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AMSWAAmerican Software Inc
09/08/202416:28Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ITRMIterum Therapeutics PLC
09/08/202416:28Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:IRAAUIris Acquisition Corporation
09/08/202416:27Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]USOTC:MOTSMotus GI Holdings Inc (QB)
09/08/202416:27Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:AMTXAemetis Inc
09/08/202416:27PR Newswire (US)Lykos Therapeutics Announces Complete Response Letter for Midomafetamine Capsules for PTSD
09/08/202416:26Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:MOTSMotus GI Holdings Inc (QB)
09/08/202416:26GlobeNewswire Inc.SBA Press Release: RO24-41, SBA Administrator Guzman Participates in Final White House Initiative on Asian American, Native Hawaiian, and Pacific Islanders Economic Summit
09/08/202416:26Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:PCOKPacific Oak Strategic Opportunity Reit Inc (PK)
09/08/202416:26Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:VXXiPath Series B S&P 500 VIX ShortTerm Futures ETN
09/08/202416:26Business WireDubai lancia un programma globale per potenziare i futuri leader delle previsioni
09/08/202416:26Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:ZURAZura Bio Ltd

Su Consulta Reciente

USOTC
BASFY
BASF (QX)
NASDAQ
AMZN
Amazon.com
NASDAQ
GOOGL
Alphabet
NYSE
BAC
Bank of America
FX
EURMXN
Euro vs MXN
NYSE
JPM
JP Morgan Chase
NASDAQ
NVDA
NVIDIA
AMEX
XLF
Financial Select Sector
NASDAQ
QQQ
Invesco QQQ Trust Series 1
SPI
SP500
S&P 500
PM
XAUUSD
Gold vs US Dollar
NASDAQ
TSLA
Tesla
NASDAQ
MSFT
Microsoft
NYSE
DIS
Walt Disney
CCOM
SILVER
SILVER
USI
USTECH100
US Tech 100
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados